Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder

Br J Psychiatry. 2008 Feb;192(2):124-9. doi: 10.1192/bjp.bp.107.037234.

Abstract

Background: There is conflicting evidence about comorbid personality pathology in depression treatments.

Aims: To test the effects of antidepressant drugs and cognitive therapy in people with depression distinguished by the presence or absence of personality disorder.

Method: Random assignment of 180 out-patients with depression to 16 weeks of antidepressant medication or cognitive therapy. Random assignment of medication responders to continued medication or placebo, and comparison with cognitive therapy responders over a 12-month period.

Results: Personality disorder status led to differential response at 16 weeks; 66% v. 44% (antidepressants v. cognitive therapy respectively) for people with personality disorder, and 49% v. 70% (antidepressants v. cognitive therapy respectively) for people without personality disorder. For people with personality disorder, sustained response rates over the 12-month follow-up were nearly identical (38%) in the prior cognitive therapy and continuation-medication treatment arms. People with personality disorder withdrawn from medication evidenced the lowest sustained response rate (6%). Despite the poor response of people with personality disorder to cognitive therapy, nearly all those who did respond sustained their response.

Conclusions: Comorbid personality disorder was associated with differential initial response rates and sustained response rates for two well-validated treatments for depression.

Publication types

  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Cognitive Behavioral Therapy / methods*
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / epidemiology
  • Depressive Disorder / psychology
  • Humans
  • Paroxetine / therapeutic use*
  • Personality Disorders / epidemiology
  • Treatment Outcome

Substances

  • Antidepressive Agents, Second-Generation
  • Paroxetine